(19)
(11) EP 3 243 821 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.04.2020 Bulletin 2020/16

(45) Mention of the grant of the patent:
26.02.2020 Bulletin 2020/09

(21) Application number: 17177006.8

(22) Date of filing: 02.05.2011
(51) International Patent Classification (IPC): 
C07D 417/06(2006.01)
A61P 29/00(2006.01)
 A61K 31/427(2006.01)

(54)

PHARMACEUTICAL FORMULATIONS FOR REGULATING INTEGRIN CD11B/CD18

PHARMAZEUTISCHE FORMULIERUNGEN ZUR REGULIERUNG VON INTEGRIN-CD11B/CD18

FORMULATIONS PHARMACEUTIQUES POUR RÉGULER L'INTÉGRINE CD11B/CD18

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 08.07.2010 US 362363 P

(43) Date of publication of application:
15.11.2017 Bulletin 2017/46

(60) Divisional application:
20159424.9

(62) Application number of the earlier application in accordance with Art. 76 EPC:
11803961.9 / 2591092

(73) Proprietor: GB006, Inc.
San Diego, CA 92121 (US)

(72) Inventor:
  • GUPTA, Vineet
    Pinecrest, FL 33156 (US)

(74) Representative: Murgitroyd & Company 
Murgitroyd House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)


(56) References cited: : 
US-A1- 2004 002 526
   
  • FARIDI MOHD H ET AL: "Identification of novel agonists of the integrin CD11b/CD18", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, vol. 19, no. 24, 15 December 2009 (2009-12-15), pages 6902-6906, XP026754144, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2009.10.077 [retrieved on 2009-10-22]
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).